95%CI	95% Confidence Interval
ALK	Anaplastic Lymphoma Kinase
APC	Antigen Presenting Cells
BOR	Best Objective Response
CRP	C-reactive Protein
CV	Coefficient of variation
DNA	Deoxyribonucleic Acid
ECOG PS	Eastern Cooperative Oncology Group Performance Status
EGFR	Epidermal Growth Factor Receptor
ELISA	Enzyme-linked immunosorbent assay
HR	Hazard Ratio
IQR	Interquartile Range
mRNA	Messenger RNA
NLR	Neutrophil to lymphocyte Ratio
NSCLC	Non-Small Cell Lung Cancer
ORR	Objective Response Rate
OS	Overall Survival
PD-1; mPD-1; sPD-1	Programmed cell death 1; membrane-bound PD-1; Soluble PD-1
PD-L1 TC	PD-L1 expression rate on tumor cells
PD-L1, PD-L2; mPD-L1, mPD-L2 sPD-L1,	Programmed death ligand 1, 2; membrane-bound PD-L1, PD-L2; Soluble PD-L1
PFS	Progression-free Survival
RECIST	Response Evaluation Criteria in Solid Tumors
RPM	Revolutions per minute
TCR	T-cell Receptor
TILs	Tumor Infiltrating Lymphocytes
TMB	Tumor Mutational Burden